Document Detail


Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions.
MedLine Citation:
PMID:  18001625     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In secondary prevention among male and female survivors of prior myocardial infarction (MI), occlusive stroke, transient ischemic attack, and other high-risk conditions, long-term use of aspirin confers very similar statistically significant and clinically important reductions in MI, stroke, and cardiovascular death. In men and women suffering acute MI or acute occlusive stroke, aspirin confers similar benefits. In primary prevention, aspirin confers a statistically significant and clinically important reduction in risk of a first MI, but the data on stroke and cardiovascular disease death remain inconclusive, so aspirin should be prescribed on an individual basis by the healthcare provider who weighs this clear benefit against long-term side effects. Worldwide, aspirin used more widely and appropriately would avoid many premature deaths in secondary prevention, during acute MI, and during acute stroke, as well as many first MI in primary prevention.
Authors:
Charles H Hennekens
Related Documents :
16344295 - Myocardial infarction in young adults.
15733315 - Acute st-segment elevation myocardial infarction after amoxycillin-induced anaphylactic...
24775505 - Cardiovascular risk factors and lifestyle associated with premature myocardial infarcti...
17527115 - Ventricular myocardial fat: ct findings and clinical correlates.
14571485 - Incidence and predictors of late total occlusion following coronary stenting.
19641675 - Evaluation of serum neopterin, high-sensitivity c-reactive protein and thiobarbituric a...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  9     ISSN:  1523-3804     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-11-16     Completed Date:  2008-03-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  409-16     Citation Subset:  IM    
Affiliation:
PROFCHHMD@prodigy.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aspirin / adverse effects,  therapeutic use*
Cardiovascular Diseases / drug therapy*,  epidemiology,  prevention & control*
Female
Humans
Male
Myocardial Infarction / drug therapy,  prevention & control*
Platelet Aggregation Inhibitors / therapeutic use*
Primary Prevention
Randomized Controlled Trials as Topic
Stroke / drug therapy,  prevention & control
Chemical
Reg. No./Substance:
0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clopidogrel and risk for acute coronary events.
Next Document:  Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipopr...